AGF Management Ltd. Has $37.88 Million Stock Position in HCA Healthcare, Inc. $HCA

AGF Management Ltd. raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,876 shares of the company’s stock after acquiring an additional 2,018 shares during the quarter. AGF Management Ltd.’s holdings in HCA Healthcare were worth $37,879,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the stock. Brighton Jones LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter valued at $1,021,000. NewEdge Advisors LLC boosted its position in HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after purchasing an additional 409 shares during the last quarter. Sivia Capital Partners LLC increased its position in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the last quarter. Janney Montgomery Scott LLC lifted its holdings in shares of HCA Healthcare by 4.5% during the 2nd quarter. Janney Montgomery Scott LLC now owns 14,633 shares of the company’s stock valued at $5,606,000 after buying an additional 636 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in HCA Healthcare by 4.9% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,837 shares of the company’s stock worth $9,515,000 after buying an additional 1,153 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the stock. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, January 28th. Leerink Partners raised their target price on HCA Healthcare from $507.00 to $573.00 and gave the company an “outperform” rating in a report on Wednesday, January 28th. Bank of America boosted their target price on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research report on Monday, October 27th. UBS Group raised their target price on HCA Healthcare from $525.00 to $598.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Finally, TD Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a report on Wednesday, January 28th. Fifteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $519.71.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $496.30 on Tuesday. The stock has a market cap of $113.25 billion, a PE ratio of 17.49, a PEG ratio of 1.50 and a beta of 1.36. The business has a fifty day moving average of $480.98 and a two-hundred day moving average of $439.27. HCA Healthcare, Inc. has a 52-week low of $295.00 and a 52-week high of $527.55.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the previous year, the business earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a $0.78 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.15%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.